Home  »  Finance   »  Iovance Biotherapeutics Inc. (IOVA) Stock Could So...

Iovance Biotherapeutics Inc. (IOVA) Stock Could Soon Reward Patient Investors

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is -1.88% lower on its value in year-to-date trading and has touched a low of $5.42 and a high of $18.73 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IOVA stock was last observed hovering at around $6.16 in the last trading session, with the day’s gains setting it 0.11%.

Currently trading at $6.27, the stock is 1.42% and -6.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.46 million and changing 1.79% at the moment leaves the stock -40.30% off its SMA200. IOVA registered -55.81% loss for a year compared to 6-month loss of -49.92%.

5 Undervalued Stocks For 2023

Approximately 544 miles north of Las Vegas lies what's been dubbed "the biggest lithium deposit in the US." One tiny company stands to be the biggest beneficiary because lithium "faces a long-term supply shortage," according to Barron's. This company, however, is sitting on a goldmine opportunity as it plans to produce 30,000 tonnes per annum over the next 3.5 years from this single deposit. Supplying the electric vehicle boom and potentially driving its stock price off the charts. But this is just one of the opportunities we have researched in our free report. The other four companies have just as much potential.

Click here to download your Free Copy…


The stock witnessed a 3.47% gain in the last 1 month and extending the period to 3 months gives it a -28.83%, and is -3.24% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.29% over the week and 6.14% over the month.

Distance from 52-week low is 15.68% and -66.52% from its 52-week high.

The EPS is expected to shrink by -18.90% this year.

Iovance Biotherapeutics Inc. (IOVA) Top Institutional Holders

The shares outstanding are 157.82M, and float is at 146.85M with Short Float at 14.78%.

Iovance Biotherapeutics Inc. (IOVA) Insider Activity

The most recent transaction is an insider purchase by MCPEAK MERRILL A,the company’sDirector. SEC filings show that MCPEAK MERRILL A bought 10,000 shares of the company’s common stock on Dec 21 at a price of $6.15 per share for a total of $61500.0. Following the purchase, the insider now owns 70150.0 shares.

Iovance Biotherapeutics Inc. disclosed in a document filed with the SEC on Dec 02 that Rothbaum Wayne P. (Director) bought a total of 10,000,000 shares of the company’s common stock. The trade occurred on Dec 02 and was made at $6.50 per share for $65.0 million. Following the transaction, the insider now directly holds 18.07 million shares of the IOVA stock.

Still, SEC filings show that on Nov 29, MCPEAK MERRILL A (Director) acquired 10,000 shares at an average price of $6.31 for $63100.0. The insider now directly holds 238,633 shares of Iovance Biotherapeutics Inc. (IOVA).

Iovance Biotherapeutics Inc. (IOVA): Who are the competitors?

The company’s main competitors (and peers) include Pfizer Inc. (PFE) that is trading -15.75% down over the past 12 months and Merck & Co. Inc. (MRK) that is 35.24% higher over the same period.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts